Neuro I
Active substance: TARAXACUM OFFICINALE, GOLDENSEAL, MELATONIN, DOPAMINE HYDROCHLORIDE, LEVODOPA, SEROTONIN HYDROCHLORIDE
LIQUID · TARAXACUM OFFICINALE 3 [hp_X]/mL, GOLDENSEAL 6 [hp_X]/mL, MELATONIN 6 [hp_X]/mL, DOPAMINE HYDROCHLORIDE 8 [hp_X]/mL, LEVODOPA 8 [hp_X]/mL, SEROTONIN HYDROCHLORIDE 8 [hp_X]/mL
United StatesActive
Marketing holder: Deseret Biologicals, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
Composition
- TARAXACUM OFFICINALE · 3 [hp_X]/mL
- GOLDENSEAL · 6 [hp_X]/mL
- MELATONIN · 6 [hp_X]/mL
- DOPAMINE HYDROCHLORIDE · 8 [hp_X]/mL
- LEVODOPA · 8 [hp_X]/mL
- SEROTONIN HYDROCHLORIDE · 8 [hp_X]/mL
Products containing melatonin in other countries
Showing products with this active substance, combinations included; the full composition is shown for each product.
| Country | Products |
|---|---|
| RU 40 |
|
| EU 3 |
|
Registration
- Registration number
- 43742-1317
- Registration status
- Active
- Dispensing
- Over the counter
- Route
- ORAL
Sources
- product · openFDA NDC · 43742-1317 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 43742-1317 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 43742-1317 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 43742-1317 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 43742-1317 · Verified 2026-10-09 · open in source
- ingredients.3 · openFDA NDC · 43742-1317 · Verified 2026-10-09 · open in source
- ingredients.4 · openFDA NDC · 43742-1317 · Verified 2026-10-09 · open in source
- ingredients.5 · openFDA NDC · 43742-1317 · Verified 2026-10-09 · open in source